HLB Therapeutics Co.,Ltd.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

49

Website

hlbtherapeutics.co.kr

Country

South Korea

Exchange

KOSDAQ

Founded 2000Seongnam-si, South Korea

HLB Therapeutics Co.,Ltd., a biotech company develops pharmaceutical products in South Korea and globally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy

OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. in December 2021.

HLB Therapeutics Co.,Ltd. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Key Stats

52-Week Range

₩1342.00₩4160.00

Beta-0.70

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.